- Home
- DFIN vs QDEL Comparison
DFIN vs QDEL Comparison
Compare DFIN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DFIN | QDEL |
|---|---|---|
| Founded | 1983 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 991.6M | 1.0B |
| IPO Year | 2017 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DFIN | QDEL |
|---|---|---|
| Price | $40.63 | $12.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $61.50 | $28.25 |
| AVG Volume (30 Days) | 368.4K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 1.27 | N/A |
| Revenue | $963,000,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $4.98 | $3.51 |
| Revenue Next Year | $3.87 | $3.86 |
| P/E Ratio | $31.61 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.11 | $9.92 |
| 52 Week High | $66.25 | $35.58 |
Technical Indicators
Market Signals| Indicator | DFIN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 44.25 |
| Support Level | $36.78 | $10.39 |
| Resistance Level | $41.22 | $12.85 |
| Average True Range (ATR) | 1.71 | 1.07 |
| MACD | 0.52 | -0.23 |
| Stochastic Oscillator | 78.46 | 11.61 |
Price Performance
Historical ComparisonAbout DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance software solutions and related services provider. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. It operates in four reportable segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management (its key revenue-generating segment), Investment Companies - Software Solutions, and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States (USA), Europe, Asia, Canada, and Others, of which the USA accounts for the vast majority of its total revenue.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.